HSP90 alpha / beta Antibody (ATTO390)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
HSP90 alpha/beta Antibody is a Mouse Monoclonal conjugated to ATTO 390 against HSP90 alpha/beta.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | HSP90 alpha/beta |
| Host | Mouse |
| Reactivity | Human, Mouse, Rat, Yeast |
| Recommended Dilution | WB: 1/1000, IHC: 1/100, IF/ICC: 1/100. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | ATTO390 |
| Isotype | IgG2a |
| Purification | Purified by Protein G. |
| Size 1 | 100 µg |
| Tested Applications | ELISA, WB, IHC, IF/ICC |
| Buffer | PBS, pH 7.2, 50% glycerol, 0.09% sodium azide. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P08238, P07900 |
| Gene ID | 3326, 3320 |
| NCBI Accession | NP_031381.2, NP_001017963.2 |
| Background | Antibody anti-HSP90 |
| Status | RUO |
| Note | Concentration: 1 mg/ml - |
Descripción
Related Products
Bovine HSP90(Heat shock protein 90) ELISA Kit
Ver Producto
anti- HSP90 antibody
HSP90, encoded by HSP90AA1, is a constitutively and ubiquitously expressed molecular chaperone that is crucial for the stability and function of many proteins. HSP90 provides chaperoning activity for client proteins; many of them are members of oncogenic pathways, indicating its implication in tumor malignancy. HSP90 mainly resides in the cytosol, while it can also be released to the extracellular space. Secreted Hsp90 is a C-terminal truncated form. It has been reported that the level of plasma Hsp90 is positively correlated with tumor malignancy in clinical cancer patients, and can be a promising diagnostic marker for tumor malignancy in clinical application.
Ver Producto
anti- HSP90 antibody
HSP90, encoded by HSP90AA1, is a constitutively and ubiquitously expressed molecular chaperone that is crucial for the stability and function of many proteins. HSP90 provides chaperoning activity for client proteins; many of them are members of oncogenic pathways, indicating its implication in tumor malignancy. HSP90 mainly resides in the cytosol, while it can also be released to the extracellular space. Secreted Hsp90 is a C-terminal truncated form. It has been reported that the level of plasma Hsp90 is positively correlated with tumor malignancy in clinical cancer patients, and can be a promising diagnostic marker for tumor malignancy in clinical application.
Ver Producto